Zobrazeno 1 - 10
of 98
pro vyhledávání: '"JR Paño Pardo"'
Autor:
JR Paño-Pardo, E Moreno Rodilla, S Cobo Sacristan, JL Cubero Saldaña, L Periañez Párraga, JL del Pozo León, P Retamar-Gentil, A Rodríguez Oviedo, MJ Torres Jaén, P Vidal-Cortes, C Colás Sanz
Publikováno v:
Journal of investigational allergologyclinical immunology.
Suspected or confirmed antibiotic allergy is a frequent clinical circumstance that influences antimicrobial prescription and often leads to the avoidable use of less efficacious and/or more toxic or costly drugs than first-line antimicrobials. Optimi
Publikováno v:
Europe PubMed Central
Increasing antibiotic resistance is one of the leading problems in the Public Agenda worldwide. In the last 20 years, the pace of antimicrobial drug development has markedly slowed leading to a dramatic world situation. Infections with antibiotic-res
Autor:
I Puértolas Tena, J Arribas García, JR Paño Pardo, MJ Cumbraos Sánchez, F. Ruiz Laiglesia, D Sánchez Fabra, S Gamarra Calvo, M.A. Allende Bandrés
Publikováno v:
Clinical pharmacy.
Background From October 2015, an Antimicrobial Stewardship Programme (ASP) was implemented in an internal medicine department by a multidisciplinary team. One of the interventions developed within this ASP was to promote the early switch of intraveno
Autor:
Jr, Paño-Pardo, López Quintana B, Lázaro Perona F, Ruiz Carrascoso G, Mp, Romero-Gómez, Loeches Yagüe B, Díaz-Pollán B, Martínez-Virto A, Jesus Mingorance, García Rodríguez J, Jr, Arribas, Gómez-Gil R
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4d13d22aaccae256c51a81a35c94344c
http://europepmc.org/abstract/med/27703997
http://europepmc.org/abstract/med/27703997
Autor:
Gupta N; Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease., Grobusch MP; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Infection and Immunity, Amsterdam Public Health, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease., Jokelainen P; Infectious Disease Preparedness and One Health, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease., Wyllie AL; Department of Global, Environmental, and Occupational Health, University of Maryland School of Public Health, College Park, Maryland, USA; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease., Barac A; Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease., Mora-Rillo M; High-Level Isolation Unit, Infectious Diseases Unit, La Paz University Hospital, IdiPAZ, Madrid, Spain; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease., Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University Hospitals & The Clinical School, University of Cambridge, Cambridge, United Kingdom; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease., Pellejero-Sagastizabal G; Servicio de Enfermedades Infecciosas / Division of Infectious Diseases, Hospital Clínico Universitario Universidad de Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón) 50009 Zaragoza, Spain; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease., Paño-Pardo JR; Servicio de Enfermedades Infecciosas / Division of Infectious Diseases, Hospital Clínico Universitario Universidad de Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón) 50009 Zaragoza, Spain; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease., Duizer E; Centre for Infectious Diseases Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease., Lescure FX; Infectious and Tropical Diseases Department, APHP, Bichat Hospital and Université Paris Cité, Inserm, IAME, F-75018 Paris, France; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease. Electronic address: xavier.lescure@aphp.fr.
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Oct 11. Date of Electronic Publication: 2024 Oct 11.
Autor:
Jokelainen P; Infectious Disease Preparedness and One Health, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Diseases. Electronic address: PIJO@ssi.dk., Wyllie AL; Department of Global, Environmental, and Occupational Health, University of Maryland School of Public Health, College Park, MD, USA; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Diseases. Electronic address: awyllie@gmail.com., Gupta N; Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Diseases. Electronic address: nityanitingupta@gmail.com., Barac A; Clinic for Infectious and tropical diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Diseases. Electronic address: aleksandrabarac85@gmail.com., Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University Hospitals & The Clinical School, University of Cambridge, Cambridge, United Kingdom; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Diseases. Electronic address: egkraniaklotsas@nhs.net., Bulescu C; Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania; Trainee Association of ESCMID, European Society of Clinical Microbiology and Infectious Diseases. Electronic address: casandrabulescu@yahoo.com., Paño-Pardo JR; Hospital Clínico Universitario Zaragoza, Zaragoza, Spain; Executive Committee, European Society of Clinical Microbiology and Infectious Diseases. Electronic address: jrpanno@unizar.es., Mora-Rillo M; High Level Isolation Unit, Infectious Diseases Unit, La Paz University Hospital, IdiPAZ, Madrid, Spain; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Diseases. Electronic address: marta.mora@salud.madrid.org., Grobusch MP; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Infection and Immunity, Amsterdam Public Health, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Diseases. Electronic address: m.p.grobusch@amsterdamumc.nl., Lescure FX; Infectious and tropical diseases department, APHP, Bichat hospital and Université Paris Cité, Inserm, IAME, F-75018 Paris, France; Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Diseases. Electronic address: xavier.lescure@aphp.fr.
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Oct 05. Date of Electronic Publication: 2024 Oct 05.
Autor:
Sesma A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Pardo J; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Microbiology, Radiology, Pediatry and Public Health Department Medicine, University of Zaragoza, 50009 Zaragoza, Spain., Isla D; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., M Gálvez E; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Instituto de Carboquímica (ICB-CSIC), Miguel Luesma 4, 50018 Zaragoza, Spain., Gascón-Ruiz M; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Martínez-Lostao L; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; Department of Microbiology, Pediatrics, Radiology and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.; Aragon Nanoscience Institute, 50018 Zaragoza, Spain.; Aragon Materials Science Institute, 50009 Zaragoza, Spain.; Immunology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain., Moratiel A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Paño-Pardo JR; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Infectious Disease Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain., Quílez E; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Torres-Ramón I; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Yubero A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Zapata-García M; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Domingo MP; Immunology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain., Esteban P; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Sanz Pamplona R; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Lastra R; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Ramírez-Labrada A; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Aug 08; Vol. 16 (16). Date of Electronic Publication: 2024 Aug 08.
Autor:
Lo Moro G; Department of Public Health and Pediatrics, University of Turin, Turin, Italy. Electronic address: giuseppina.lomoro@unito.it., Marengo N; Department of Public Health and Pediatrics, University of Turin, Turin, Italy., Mara A; Department of Public Health and Pediatrics, University of Turin, Turin, Italy., Paño Pardo JR; Fundación Instituto de Investigación Sanitaria Aragón (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), Zaragoza, Spain; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Hernandez S; Centro Coordinador Programa VINCat, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain., Fusté E; Department of Public Health, Mental Health and Maternal and Child Health Nursing, Faculty of Nursing. University of Barcelona, Spain; Department of Pathology and Experimental Therapeutics, University of Barcelona and IDIBELL, Faculty of Medicine and Health Sciences University of Barcelona, L'Hospitalet de Llobregat, Spain., Pujol M; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; VINCat Program, Servei Català de la Salut, Barcelona, Spain., Zotti CM; Department of Public Health and Pediatrics, University of Turin, Turin, Italy., Limón E; Centro Coordinador Programa VINCat, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Department of Public Health, Mental Health and Maternal and Child Health Nursing, Faculty of Nursing. University of Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Vicentini C; Department of Public Health and Pediatrics, University of Turin, Turin, Italy.
Publikováno v:
Journal of infection and public health [J Infect Public Health] 2024 Jul; Vol. 17 (7), pp. 102457. Date of Electronic Publication: 2024 May 24.
Autor:
Yonga P; Tropical/Travel Medicine and Infectious Diseases Clinic, CA Medlynks Medical Centre and Laboratory, Nairobi, Kenya. Electronic address: ypaul.py@gmail.com., Pulcini C; Université de Lorraine, UMR 1319 Inserm INSPIIRE, and Université de Lorraine, CHRU-Nancy, Centre Régional en Antibiothérapie du Grand Est AntibioEst, Nancy, France., Skov R; Epidemiological Infectious Disease Preparedness; Statens Serum Institut, and International Centre for Antimicrobial Resistance Solutions, Copenhagen, Denmark., Paño-Pardo JR; Hospital Clínico Universitario Lozano Blesa, and Universidad de Zaragoza. IIS Aragón. CIBERINFEC, Zaragoza, Spain., Schouten J; Department of Intensive Care Medicine, Radboudumc, Nijmegen, the Netherlands.
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Jul; Vol. 30 (7), pp. 848-849. Date of Electronic Publication: 2024 Apr 06.
Autor:
Senan-Salinas A; Instituto de Carboquímica ICB-CSIC, 50018 Zaragoza, Spain., Comas L; Instituto de Carboquímica ICB-CSIC, 50018 Zaragoza, Spain., Esteban P; Fundación Instituto de Investigación Sanitaria Aragón (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), 50009 Zaragoza, Spain., Garzón-Tituaña M; Dept. Microbiology, Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029Madrid, Spain., Cheng Z; Centre for Inflammation Research, The University of Edinburgh, EH164UU Edinburgh, U.K.; IRR Chemistry Hub, Institute for Regeneration and Repair, The University of Edinburgh, EH16 4UU Edinburgh, U.K., Santiago L; Instituto de Carboquímica ICB-CSIC, 50018 Zaragoza, Spain., Domingo MP; Instituto de Carboquímica ICB-CSIC, 50018 Zaragoza, Spain., Ramírez-Labrada A; Fundación Instituto de Investigación Sanitaria Aragón (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), 50009 Zaragoza, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029Madrid, Spain.; Unidad de Nanotoxicología e Inmunotoxicología (UNATI), Centro de Investigación Biomédica de Aragón (CIBA), Aragón Health Research Institute (IIS Aragón), 50009Zaragoza, Spain., Paño-Pardo JR; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029Madrid, Spain.; Servicio de Enfermedades Infecciosas, Hospital Clinico Universitario Lozano Blesa, 50009 Zaragoza, Spain., Vendrell M; Centre for Inflammation Research, The University of Edinburgh, EH164UU Edinburgh, U.K., Pardo J; Fundación Instituto de Investigación Sanitaria Aragón (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), 50009 Zaragoza, Spain.; Dept. Microbiology, Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029Madrid, Spain., Arias MA; Fundación Instituto de Investigación Sanitaria Aragón (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), 50009 Zaragoza, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029Madrid, Spain., Galvez EM; Instituto de Carboquímica ICB-CSIC, 50018 Zaragoza, Spain.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029Madrid, Spain.
Publikováno v:
ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2024 Apr 22; Vol. 7 (5), pp. 1474-1484. Date of Electronic Publication: 2024 Apr 22 (Print Publication: 2024).